Dysregulation of vitamin D3 synthesis leads to enhanced cholangiocarcinoma growth
Authors:
- Kimberly BakerKBKimberly Baker
- Kyle HodgesKHKyle Hodges
- Allyson GrafAGAllyson Graf
- Julie VenterJVJulie Venter
- Laura HargroveLHLaura Hargrove
- Rachel HarrisRHRachel Harris
- Evan HarnishEHEvan Harnish
- Fanyin MengFMFanyin Meng
- Heather FrancisHFHeather Francis
- 1 April 2013
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 45 (4) , 316-322
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Dysregulated Krüppel-Like Factor 4 and Vitamin D Receptor Signaling Contribute to Progression of Hepatocellular CarcinomaGastroenterology, 2012
- CYP24 inhibition preserves 1α,25-dihydroxyvitamin D3 anti-proliferative signaling in lung cancer cellsMolecular and Cellular Endocrinology, 2012
- Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanismsLaboratory Investigation, 2011
- Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growthAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaGut, 2011
- CYP24A1Is an Independent Prognostic Marker of Survival in Patients with Lung AdenocarcinomaClinical Cancer Research, 2011
- H3 Histamine Receptor–Mediated Activation of Protein Kinase Cα Inhibits the Growth of CholangiocarcinomaIn vitroandIn vivoMolecular Cancer Research, 2009
- Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor GrowthCancer Research, 2008
- Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathwayAmerican Journal of Physiology-Cell Physiology, 2008
- Vitamin D signalling pathways in cancer: potential for anticancer therapeuticsNature Reviews Cancer, 2007